VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
Navdeep TangriVandana S MathurDavid A BushinskyGerrit KlaernerElizabeth LiDawn ParsellYuri StasivMichael WalkerDonald E WessonDavid Collins WheelerVlado PerkovicLesley A InkerPublished in: Journal of the American Society of Nephrology : JASN (2024)
VALOR-CKD, NCT03710291 .